Phase II study of gemcitabine and vinorebline in patients with persistent or recurrent platinum-resistant ovarian or primary peritoneal cancer: A study of the Korean Cancer Study Group.

被引：0
|
作者：
Hong, Sook Hee
Byun, Jae Ho
Lee, Soohyeon
Kim, Hoon-Gu
Lee, Hyo Jin
Jung, Kyung Hae
Lee, Sang-Cheol
Lee, Na-Ri
Yun, Jina
Hong, Dae-Sik
Woo, In Sook
Park, Kyong Hwa
Rha, Sun Young
机构：
[1] Catholic Univ Korea, Div Oncol, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea
[2] Catholic Univ Korea, Incheon St Marys Hosp, Inchon, South Korea
[3] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea
[4] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea
[5] Chungnam Natl Univ, Dept Internal Med, Coll Med, Taejon, South Korea
[6] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
[7] Soonchunhyang Univ, Coll Med, Div Hematol Oncol, Dept Internal Med,Hosp Seoul, Seoul, South Korea
[8] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea
[9] Soonchunhyang Univ, Bucheon Hosp, Bucheon, South Korea
[10] Catholic Univ Korea, Yeouido St Marys Hosp, Seoul, South Korea
[11] Korea Univ, Coll Med, Div Hematol & Oncol, Dept Internal Med,Anam Hosp, Seoul 136705, South Korea
[12] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[13] Brain Korea 21 Project Med Sci, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5568
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer
    Garcia, AA
    O'Meara, A
    Bahador, A
    Facio, G
    Jeffers, S
    Kim, DY
    Roman, L
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 493 - 498
  • [2] Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
    Cannistra, Stephen A.
    Matulonis, Ursula A.
    Penson, Richard T.
    Hambleton, Julie
    Dupont, Jakob
    Mackey, Howard
    Douglas, Jeffrey
    Burger, Robert A.
    Armstrong, Deborah
    Wenham, Robert
    McGuire, William
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5180 - 5186
  • [3] Weekly gemcitabine in patients with relapsed platinum-resistant ovarian or peritoneal cancer. Results of phase II study
    Czerniawska, Malgorzata
    Jagiello-Gruszfeld, Agnieszka
    Zbrzezniak, Jolanta
    Wachula, Ewa
    Szablowska-Siwik, Sylwia
    Sikorska, Magdalena
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [4] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Nagao, Shoji
    Kogiku, Ai
    Suzuki, Kazuhiro
    Shibutani, Takashi
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [5] A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Shoji Nagao
    Ai Kogiku
    Kazuhiro Suzuki
    Takashi Shibutani
    Kasumi Yamamoto
    Tomoatsu Jimi
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Satoshi Yamaguchi
    Journal of Ovarian Research, 13
  • [6] Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
    Hong, Sook Hee
    Lee, Soohyeon
    Kim, Hoon-Gu
    Lee, Hyo Jin
    Jung, Kyung Hae
    Lee, Sang-Cheol
    Lee, Na-Ri
    Yun, Jina
    Woo, In Sook
    Park, Kyong Hwa
    Kim, Kyoung-ha
    Kim, Ho Young
    Rha, Sun Young
    Byun, Jae Ho
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 212 - 217
  • [7] Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer
    Garcia, Agustin A.
    Yessaian, Anne
    Huyen Pham
    Facio, Grace
    Muderspach, Laila
    Roman, Lynda
    CANCER INVESTIGATION, 2012, 30 (04) : 295 - 299
  • [8] Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
    Miller, David S.
    Blessing, John A.
    Krasner, Carolyn N.
    Mannel, Robert S.
    Hanjani, Parviz
    Pearl, Michael L.
    Waggoner, Steven E.
    Boardman, Cecelia H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) : 2686 - 2691
  • [9] A FEASIBILITY STUDY OF GEMCITABINE AND BEVACIZUMAB IN WOMEN WITH PLATINUM-RESISTANT RECURRENT OVARIAN CANCER
    Nagao, S.
    Kogiku, A.
    Ota, M.
    Yamamoto, K.
    Narita, M.
    Shimada, K.
    Nagazawa, H.
    Shibutani, T.
    Yamamoto, K.
    Jimi, T.
    Yano, H.
    Kitai, M.
    Shiozaki, T.
    Matsuoka, K.
    Yamaguchi, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A501 - A501
  • [10] Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: A gynecologic group study
    Fracasso, PM
    Blessing, JA
    Morgan, MA
    Sood, AK
    Hoffman, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2856 - 2859
12345